0000899243-21-008402.txt : 20210226 0000899243-21-008402.hdr.sgml : 20210226 20210226160303 ACCESSION NUMBER: 0000899243-21-008402 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210224 FILED AS OF DATE: 20210226 DATE AS OF CHANGE: 20210226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Barclay Alec CENTRAL INDEX KEY: 0001734339 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 21688637 MAIL ADDRESS: STREET 1: 101 HARTWELL AVE. CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-24 0 0001492674 T2 Biosystems, Inc. TTOO 0001734339 Barclay Alec 101 HARTWELL AVENUE LEXINGTON MA 02421 0 1 0 0 Chief Operations Officer Restricted Stock Units 2021-02-24 4 A 0 505464 0.00 A Common Stock 505464 505464 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in three equal annual installments commencing on February 24, 2022. /s/ John Sprague, Attorney-in-fact 2021-02-26